High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS
Simon Thebault(University of Pennsylvania), Mark S. Freedman(University of Ottawa), Douglas L. Arnold(McGill University), Daniel Tessier(Montreal Neurological Institute and Hospital), Amit Bar‐Or(University of Pennsylvania), Vincent Tabard‐Cossa(University of Ottawa), Marjorie A. Bowman(United States Department of Veterans Affairs), Hyunwoo Lee(Princess Alexandra Hospital), Harold Atkins(University of Ottawa)
Cited by 63
Related Papers
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k